AI summary by TwinMind
The Global Vitamin Cartels
Asianometry
22m 11s
Historical Discovery of Vitamins
- Vitamins = organic molecules essential for survival in small quantities
- Ancient knowledge of food-health connections
- Ancient Egyptians: liver consumption prevents night blindness (vitamin A)
- Chinese medicine: Inner Cannon of Yellow Emperor (claimed 2,697 BC) referenced beriberi-like disease
- Roman doctor Soranus of Ephesus (110-130 AD): described infant rickets
- James Lind (1747): lime/lemon juice prevents scurvy
- Scientific breakthrough: Christian Eijkman (1890s Dutch physician in Indonesia)
- Studied beriberi disease
- Discovered polished rice caused disease in chickens, unpolished rice cured it
- Frederick Hopkins (1906): theorized "accessory food factors"
- Casimir Funk (1912): Polish-American biochemist
- Isolated what he thought was anti-beriberi agent (actually B3, not B1)
- Coined term "vitamina" (later shortened to "vitamin")
Vitamin Discovery Timeline
- 1910s: Vitamin A, some B vitamins discovered
- 1920-1950: Vitamins C, D, E, K, additional B vitamins
- 1948: Vitamin B12 (last vitamin discovered)
- 6 Nobel Prize winners contributed to discovery
- Helped treat pernicious anemia (affected 1 in 1,000 people, previously untreatable before 1926)
Industrial Production Development
- Early extraction from natural sources (cod liver oil)
- Chemical synthesis methods developed
- Reichstein process for vitamin C (7-step process)
- Glucose → sorbitol → sorbose (via microbe fermentation) → KG acid → vitamin C
- Large-scale production by 1930s: vitamins E, C, B1, B2, B3, B4
- Vitamin A entered high-volume production 1947
Industry Players and Market Structure
Roche (Switzerland)
- Founded late 1880s by Fritz Hoffmann in Basel
- Initially hormones/vitamin extraction business
- 1933: Licensed Reichstein process for vitamin C
- Became world's leading vitamin supplier by 1939 (vitamins B, C, E)
- Maintained monopoly positions average 2 decades per vitamin
Competition Emergence
- 1960s: European and Japanese competition
- BASF (Germany): entered vitamin A market late 1960s
- Rhône-Poulenc/RP (France): produced A, E, D3, B12
- Japanese companies (late 1950s-1960s):
- Takeda: first Japanese multivitamin producer (1950), vitamin C exports to US (1955)
- Asahi, Daiichi: significant market shares in specific vitamins
- Big Three Europeans: Roche, BASF, RP held 60% world production by 1980s
Market Characteristics
- Total market value: $3-4 billion annually (1990s)
- Usage breakdown:
- 30% for supplements
- 92% vitamin C for human consumption
- 73% vitamins E and A for animals
- High technical barriers to entry
- Trade secret processes
- Chemical intermediaries not openly available
- Synergies of scale advantages
- Commodity products with no differentiation except price/purity
- Small, fragmented buyers (largest like Coca-Cola = 2% market share)
- 3-5 companies control 95% capacity in each vitamin market
Early Cartel Allegations (1970s)
- 1973: Stanley Adams (Roche executive) leaked documents to European Commission
- Revealed customer loyalty rebates violating European law
- Roche fined £140,000
- Adams arrested under Swiss law, wife committed suicide
- 1984: Adams wrote "Roche versus Adams" alleging price-fixing meetings
- 1994: Adams jailed 10 years for plotting wife's murder
Vitamin Cartel Formation (1989-1999)
Initial Formation
- 1980s: Brutal competition, prices fell dramatically
- June 7, 1989: Roche-BASF top-level meeting in Basel
- August 1989: Second meeting in Zurich including RP executives
- September 1989: Chairman/division heads meeting
- Agreement: freeze 1988 market shares, divide future markets via sales quotas
- System called "the budget" tracked with spreadsheets/databases
- Principle: "price before volume"
Cartel Operations
- 1990: Slowly raised vitamin A and E prices to pre-crisis levels
- Recruited Asahi (allocated 1,600 tons vitamin E market)
- Regular meetings at various levels to ensure compliance
- Punishment system: price cuts against suspected cheaters (Daiichi 1993)
- Expanded to other vitamins:
- B1, B6, B9 (folic acid): 45-60% market control
- C, B2, B5, beta-carotene: separate cartel
Chinese Disruption
- 1970s: Chinese Academy of Sciences developed 2-step vitamin C process
- Simplified from 7-step Reichstein process
- Direct fermentation to KG acid, then vitamin C
- 1990s: Economic liberalization under Deng Xiaoping
- 1995: 20+ Chinese state-owned firms entered global market
- Took 20% vitamin C market share, collapsed that cartel
- B1 cartel attempt (1991): tried raising prices 65 to 74-76 Deutsch marks
- Chinese surge forced cartel dissolution June 1994
Cartel Discovery and Prosecution
Investigation Trigger
- 1992: ADM lysine cartel investigation
- Mark Whitacre (ADM division president) went to FBI, wore wire
- 1996: ADM paid $100 million fine
- Investigation traced back to Roche vitamin cartels
- 1997: Roche, BASF, RP initially denied allegations
Breakthrough
- Pressure on smaller B3 vitamin cartel manufacturers
- Late 1998: RP agreed to cooperate (possibly related to $22 billion Hoechst merger)
- RP's evidence/testimony used against Roche and BASF
- Companies quickly caved for lower penalties
Penalties (May 1999)
- Total fines: $1 billion USD
- Roche: $500 million (highest fine)
- European Commission unaware until US investigation
- Roche spokesperson: "can't dispute facts... situation behind us, paid dearly"
Impact and Aftermath
Consumer Impact
- Retail consumers minimally affected (30% markup absorbed most increase)
- Overcharged approximately 1% throughout cartel existence
- Companies (animal feed, food manufacturers) most affected
Industry Changes
- Roche sold vitamins division to DSM (Switzerland)
- BASF announced sale of human nutrition division to Louis Dreyfus
- Rise of Chinese dominance in food material supply
- Concern about specialty goods import market concentration
